Boston Partners International Equity (S:0P00009PVL)
26.79
+0.14
(+0.54%)
USD |
Nov 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 30, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| BAE Systems Plc | 2.99% | 22.91 | -3.21% |
| The Weir Group Plc | 2.89% | 36.67 | -4.34% |
| Samsung Electronics Co., Ltd. | 2.80% | 65.21 | 0.00% |
| Heineken NV | 2.40% | 82.32 | 1.50% |
| Alibaba Group Holding Ltd. | 2.38% | 18.81 | 7.49% |
| Danske Bank A/S | 2.17% | 51.18 | 0.00% |
| Babcock International Group Plc | 2.16% | 16.17 | -1.65% |
| NAVER Corp. | 2.12% | 115.00 | 0.00% |
| Sumitomo Mitsui Financial Group, Inc. | 2.02% | 33.56 | 3.03% |
| AstraZeneca PLC | 1.87% | 180.85 | -3.32% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |